Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03906422 · ClinicalTrials.gov registry record · NA

Comparison of Patient-reported Pain After Initial Archwire Placement

A NA study of Pain, Orofacial and Orthodontic Discomfort, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
126
Enrollment target
1
Study location

NCT03906422: Recruiting NA study of Pain, Orofacial and Orthodontic Discomfort, sponsored by University of Colorado, Denver.

NCT03906422 is a NA study of Pain, Orofacial and Orthodontic Discomfort that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 126 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03906422, a NA study of Pain, Orofacial and Orthodontic Discomfort, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
126 participants
Enrollment target
1
Study location

Study Summary

Three different types of 'archwires' can be used in Orthodontic treatment, wire choice is decided by treating Orthodontist based on professional preference since research shows that all types are equally effective. It is possible that one type of wire engenders more patient discomfort. This study will compare the discomfort levels engendered by the three wire types to determine if there is one that induces the least amount.

Primary Outcome

The primary outcome is the change in pain experienced by the study participant over the first week of therapy after insertion of the archwire. Pain is assessed by asking the study participant to place a mark on a horizontal 100 mm line to indicate the level of pain being experienced. The left end of the line is no pain where the right end is maximum (unimaginable) pain. The specific pain indicated is in the number of millimeters from the left end of the line. This is called the Visual Analogue

Interventions

  • DEVICE 3M Unitek 0.016 orthodontic archwire
  • DEVICE Device: 0.016" Ormco 27oC NiTi orthodontic archwire
  • DEVICE Device: 0.016" Ormco 35oC NiTi orthodontic archwire

Study Locations (1)

Colorado

  • University of Colorado School of Dental Medicine - Aurora

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2019-05-10
Est. Completion 2028-06-01
Phase NA
University of Colorado, Denver

1,283 total trials

What NCT03906422 shows while recruiting

NCT03906422 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 2 conditions, with Pain, Orofacial appearing as the primary indexed condition, and to 3 interventions - of which 3M Unitek 0.016 orthodontic archwire is the first listed.

NCT03906422 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT03906422 about?

NCT03906422 is a clinical study titled "Comparison of Patient-reported Pain After Initial Archwire Placement". Three different types of 'archwires' can be used in Orthodontic treatment, wire choice is decided by treating Orthodontist based on professional preference since research shows that all types are equally effective. It is possible that one type of wire engenders more patient discomfort. This study w...

What is the current status of trial NCT03906422?

This trial is currently recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2019-05-10. Estimated completion is 2028-06-01.

What conditions does trial NCT03906422 study?

This clinical trial studies the following conditions: Pain, Orofacial, Orthodontic Discomfort.

What interventions are being tested in trial NCT03906422?

The interventions under investigation include: 3M Unitek 0.016 orthodontic archwire (DEVICE), Device: 0.016" Ormco 27oC NiTi orthodontic archwire (DEVICE), Device: 0.016" Ormco 35oC NiTi orthodontic archwire (DEVICE).

Who is sponsoring clinical trial NCT03906422?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03906422 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Orofacial

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03906422's enrollment target sits among peer trials

126 749th of 2000 higher than 1,248 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT04379115 · 126 participants · NA

    Optimization of NIBS for Treatment of Addiction

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03906422, the US trial registry maintained by the National Library of Medicine. NCT03906422 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.